As the Centers for Medicare and Medicaid Services calls for public feedback on how to stop lab test fraud, experts say a ...

The global molecular diagnostics market is projected to reach USD 33.51 billion by 2031, driven by expanding precision medicine adoption and advanced genetic testing. North America leads the market, ...

Expanding access to advanced PCR thermocyclers, DNA & RNA purification systems, and hematology analyzers for modern clinical ...

The owner of a business in Greenville, South Carolina, and two of his employees have been indicted in a multi-part scheme to ...

In oncology care, respiratory can pose serious risks—especially when diagnostic delays disrupt treatment decisions. Yet many clinical labs still rely | Ebooks ...

Three-site reproducibility study completed by Tampa General Hospital, Mayo Clinic, and Baylor Scott & White HealthSufficient clinical samples ...

December 2024 was declared a "high severity" flu season by the Centre for Disease Control (CDC), the worst in over half a decade. Hospitalization rates were up to 2.8 times higher than the median ...

Drug discovery is like molecular Tetris. Chemists snap atoms together, adjusting the pieces until everything fits, and ...

Strategic partnership delivers scalable, CLIA-certified capillary blood testing to support rural Medicaid programs and ...

NeoGenomics announced the launch of RaDaR® ST, its circulating tumor DNA assay for detecting molecular residual disease.

Electrons can be "kicked across" solar materials at almost the fastest speed nature allows, scientists have discovered, ...

Insight Molecular Diagnostics completes major milestones to support GraftAssureDx test kit trial for in vitro diagnostic for US FDA submission: Nashville, Tennessee Thursday, Marc ...